Reporting to associate
director Jo Wunder, Misuri-Charkham will work on
accounts including Merck's osteoporosis drug Fosamax (for Europe), as well as Nabi Biopharmaceuticals. Nabi is working on a nicotine vaccine to help smokers quit.
Ogilvy is yet to fill the void left by associate director
Brian Tjugum, who also joined WS.
Meanwhile, Dafni Kokkidi and Stephen Cull have been promoted to account managers.